News

CALL FOR PAPERS JANUARY 2026

IJSAR going to launch new issue Volume 07, Issue 01, January 2026; Open Access; Peer Reviewed Journal; Fast Publication. Please feel free to contact us if you have any questions or comments send email to: editor@scienceijsar.com

IMPACT FACTOR: 6.673

Submission last date: 20th January 2026

A descriptive, retrospective cross-sectional study on the age wise distribution and antimicrobial resistance patterns of clinical bacterial isolates in a hospital in Al-Hilla city 2024-2025

×

Error message

  • Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
  • Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
  • Deprecated function: implode(): Passing glue string after array is deprecated. Swap the parameters in drupal_get_feeds() (line 394 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
Author: 
Zahraa Saadi Jassim, Duaa R.Sadiq, Noor Anwer Abdulameer, Aya Lazim Kadhim, Mohammed S. Manji, Baneen Hadi Hashim and Rafeef Mousa Abdalhussin
Page No: 
10254-10258

Antimicrobial resistance (AMR) has become a global public health concern, with increasing prevalence across all age groups. This study aimed to evaluate the distribution and resistance patterns of bacterial pathogens isolated from patients of different age groups in a hospital in Al_ Hilla during the years 2024 _ 2025. A retrospective analysis was conducted using laboratory data from bacterial cultures and antibiotic sensitivity tests. The results showed that multidrug-resistant organisms (MDR) were most prevalent among elderly patients, while younger age groups exhibited higher susceptibility to commonly used antibiotics. Escherichia coli and p. aeruginosa were the most frequently isolated organisms. The findings highlight the need for age-specific antibiotic stewardship strategies and continuous surveillance to combat the rise of drug-resistant infections.

Download PDF: